LLY compared with HIND: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

HINDVyome Holdings, Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

HINDVyome Holdings, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

HIND: latest quarter is a loss; flow not drawable.Method ›

LLYELI Lilly & Co

1,441.95▲+1.69%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

HINDVyome Holdings, Inc

1.75▼−1.41%

Regular sessionNov 5 '26

Mkt cap$12.2MRevenue$26,955Q2 FY26Revenue—

Compare

Regular sessionNov 5 '26

LLYELI Lilly & Co

HINDVyome Holdings, Inc

1,441.95▲+1.69%

Price

1.75▼−1.41%

$1.3T

Mkt cap

$12.2M

Q3 FY26$24.4B

Revenue

$26,955Q2 FY26

FY25$65.2B

Revenue

—

LLY1,441.95▲+1.69%vsHIND1.75▼−1.41%Regular sessionNov 5 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No disclosed counterparties: HIND.

Only HIND 0

None

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

LLY, solidHIND, dashed